New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway

ZH Tang, J Peng, Z Ren, J Yang, TT Li, TH Li, Z Wang… - Atherosclerosis, 2017 - Elsevier
Background and aims Proprotein convertase subtilisin/kexin 9 (PCSK9) has emerged as a
popular target in the development of new cholesterol-lowering drugs and therapeutic …
被引用次数：247 相关文章

New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.

ZH Tang, J Peng, Z Ren, J Yang, TT Li, TH Li… - …, 2017 - europepmc.org
BACKGROUND AND AIMS: Proprotein convertase subtilisin/kexin 9 (PCSK9) has emerged
as a popular target in the development of new cholesterol-lowering drugs and therapeutic …

[引用][C] New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway

ZH Tang, J Peng, Z Ren, J Yang, TT Li, TH Li, Z Wang… - Atherosclerosis, 2017 - cir.nii.ac.jp
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB
pathway | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway

ZH Tang, J Peng, Z Ren, J Yang, TT Li… - …, 2017 - atherosclerosis-journal.com
Background and aims Proprotein convertase subtilisin/kexin 9 (PCSK9) has emerged as a
popular target in the development of new cholesterol-lowering drugs and therapeutic …

New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway

ZH Tang, J Peng, Z Ren, J Yang, TT Li… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Background and aims Proprotein convertase subtilisin/kexin 9 (PCSK9) has emerged as a
popular target in the development of new cholesterol-lowering drugs and therapeutic …